Denial for Lack of a Linked Injectable Drug Code Specific Denial: Claim denied because the injectable drug administered is not billed alongside CPT 96372
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA." Lancet , 2023;402:529-544
Product, services and providers are not warranted or endorsed
Lab costs are separate from your medicationPlexusDx's flat-rate pricing ($189/month for semaglutide injection) covers your medication regardless of dose adjustments, with no insurance or membership fees required
What GLP-1s are and how they work GLP-1s are prescription-only medications that help regulate glucose levels released in the blood stream, resulting in a reduced appetite